ПРОПАФЕНОН: КЛИНИЧЕСКАЯ ФАРМАКОЛОГИЯ И ЭФФЕКТИВНОСТЬ ПРИ СУПРАВЕНТРИКУЛЯРНЫХ ТАХИАРИТМИЯХ (Часть вторая)
Аннотация
Пропафенон: клиническая фармакология и эффективность при суправентрикулярных тахиаритмиях (часть вторая).
Об авторах
Д. В. Преображенский
Медицинский центр Управления делами Президента Российской Федерации. Кардиологический научно- производственный комплекс МЗРФ, Москва
Россия
Россия
А. В. Маренич
Медицинский центр Управления делами Президента Российской Федерации. Кардиологический научно- производственный комплекс МЗРФ, Москва
Россия
Россия
Т. А. Андрейченко
Медицинский центр Управления делами Президента Российской Федерации. Кардиологический научно- производственный комплекс МЗРФ, Москва
Россия
Россия
В. Г. Киктев
Медицинский центр Управления делами Президента Российской Федерации. Кардиологический научно- производственный комплекс МЗРФ, Москва
Россия
Россия
Б. А. Сидоренко
Медицинский центр Управления делами Президента Российской Федерации. Кардиологический научно- производственный комплекс МЗРФ, Москва
Россия
Россия
Список литературы
1. Harron D.W.G., Brogden R.N. Propafenone: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in cardiac arrhythmias. – Drugs, 1987; 34: 617-647.
2. Bryson H.M., Palmer K.J., Langtry H.D. et al. Propafenone: a reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias. – Drugs, 1993; 45 (1): 85-130.
3. Kishore A.G.R., Camm A.J. Guidelines for the use of propafenone in treating supraventricular arrhythmias. – Drugs, 1995; 50 (2): 250-262.
4. Khan I.A. Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation. — J. Am. Coll. Cardiol., 2001; 37 92): 542-547.
5. Bellandi F. et al. The efficacy of intravenous propafenone and amiodarone in conversion of recent onset atrial fibrillation: A 1 year follow-up with oral treatment. — G. Ital. Cardiol., 1993; 23: 261-271.
6. Negrini M. et al. Propafenone compared with amiodarone for conversion of paroxysmal atrial fibrillation to sinus rhythm. — J. Amer. Coll.. Cardiol., 1991; 17: 131A (abstract).
7. Bertini G. et al. Alandi F. et al. Propafenone versus amiodarone in field treatment of primary atrial tachyarrhythmias. — J. Emerg. Med., 1990; 8: 15-20..
8. Kingma J.H. et al. Acute pharmacological cardioversion of atrial fibrillation and flutter: the role of flecainide, propafenone and verapamil. — Am. J. Cardiol., 1992; 70: 56A-61A.
9. Capucci A. et al. A placebo controlled study comparing oral propafenone to quinidine plus digoxin in conversion of recent onset atrial fibrillation. – Europ. Heart J., 1991; 12 (suppl.): 338 (abstract).
10. Capucci A. et al. Conversion of recent onset atrial fibrillation by single loading dose of propafenone or flecainide. — Am. J. Cardiol., 1994; 74: 503-505.
11. Bianconi L. et al. Effectveness of intravenous propafenone for conversion of atrial fibrillation and flutter of recent onset. – Am. J. Cardiol., 1989; 64: 335-338.
12. Margheri M. et al. Efficacy of intravenous and per oral propafenone in the ambulatory treatment of recent onset atrial fibrillationus rhythm. — G. Ital. Cardiol., 1992; 22: 257-265.
13. Vita J.A. et al. The efficacy of intravenous propafenone for the acute management of atrial fibrillation. – Am. J. Cardiol., 1989; 63: 1275-1278.
14. .Kochiadakis G.E. et al. Amiodarone versus propafenone for cardioversion of chronic atrial fibrillation: results of a randomized, controlled study. — J. Am. Coll. Cardiol., 1999; 33: 966-971.
15. Capucci A. et al. Minimal effective concentration value of propafenone and 5-hydroxypropafenone in acute and chronic therapy. – Cardiovascular. Drugs Therapy, 1990; 4: 281-287.
16. Boriani G. et al. Propafenone for conversion of recent—onset atrial fibrillation: A controlled comparison between oral loading dose and intravenous administation. – Chest, 1995; 108: 355-358.
17. Botto G.L. et al. A randomized, crossover, controlled comparison of oral loading dose versus intravenous infusion of propafenone in recent onset atrial fibrillation. – Pacing Clin Electrophysiol., 1998; 21: 240-244.
18. Reinold S.C. et al. Propafenone versus sotalol for suppression of rcurrent symptomatic atrial fibrillation. – Am. J. Cardiol., 1993; 71: 558-563.
19. Boriani G. et al. Conversion of recent onset atrial fibrillation to sinus rhythm: effect of different drug protocols. — Pacing Clin Electrophysiol., 1998; 21: 2470-2474.
20. Boriani G. et al. Oral propafenone to convert recent onset atrial fibrillation in patients with and without underlying heart disease: A randomized, controlled trial. – Ann. Intern. Med., 1997; 126: 621-625.
21. Azpitarte J. et al. Value of single oral loading dose of propafenone in converting recent onset atrial fibrillation: Results of a randomized, double-blind, controlled study. Europ. Heart J., -1997; 18: 1649-1654.
22. Botto G.L et al. Conversion of recent onset atrial fibrillation to sinus rhythm using a single loading oral dose of propafenone: Comparison of two regims. – Int. J. Cardiol., 1997; 58: 55-61.
23. Boriani G. et al. Oral loading with propafenone: A placebo-controlled study in elderly and nonelderly patients with recent onset atrial fibrillation. – Pacing Clin Electrophysiol., 1998; 21: 2465-2469.
24. Botto G.L. et al. Сonversion of recent onset atrial fibrillation with single loading dose of propafenone: Is in-hospital admission absolutely necessary? – Pacing Clin Electrophysiol., 1996; 19: 1939-1943.
25. Capucci A. et al. A controlled study on oral propafenone versus digoxin plus quinidine in converting recent-onset atrial fibrillation to sinus rhythm. — Int. J. Cardiol., 1994; 41: 305-313.
26. Blanc J.J. et al. Comparison of oral loading dose of propafenone and amiodarone for conversion of recent-onset atrial fibrillation: A prospective parallel placebo-controlled multicentre study. – Am. J. Cardiol., 1999; 84: 1029-1032.
27. Capucci A. et al. Conversion of recent onset atrial fibrillation by single loading dose of propafenone or flecainide. — Am. J. Cardiol., 1994; 74: 503-505.
28. Capucci A. et al. Safety of oral propafenone in the conversion recentonset atrial fibrillation to sinus rhythm: A prospective parallel placebo-controlled multicenter study. – Am. J. Cardiol., 1999; 84: 1029-1032.
29. Bianconi L. et al. Effects of oral propafenone administration defore electrical cardioversion of chronic atrial fibrillation: A placebocontrolled study. — J. Am. Coll.. Cardiol., 1996; 28 (3): 700-706.
30. Antmann E,M. et al. Long-term oral propafenone threapy for suppression of refractory symptomatic atrial fibrillation and flutter. – J. Am. Coll. Cardiol., 1988; 12: 1005-1111.
31. Cobbe S.M. A randomised, placebo controlled trial of propafenone in the prophylaxis of of paroxysmal paroxysmal tachyarrhthmias. – J. Am. Coll. Cardiol., 1994; 23 (suppl. A): 251A (abstract). 32. Cobbe S.M. Drug therapy of supraventricular tachyarrhythmias – based on efficacy or futility? – Europ. Heart J., 1994; 15 (suppl. A): 22-26.
32. Reinold S.C. et al. Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. – Am. J. Cardiol., 1993; 71: 558-563.
33. Richardi E. et al. Propafenone versus hydroquinidine in long-term pharmacologic prophilaxis of atrial fibrillation. – Cardiology, 1992; 37: 123-127.
34. Chimenti M. et al. Flecainide versus propafenone in the prevention of paroxysmal atrial fibrillation: A long-term randomised muli-centre study. J. Am. Coll. Cardiol., 1994; 16 (suppl.): 91A (abstract)..
35. Reinold S.C. et al. Propafenone for treatment of supraventricular tachycardia: and atrial fibrillation.: A meta-analysis. – Am. J. Cardiol., 1998; 82: 66N-71N..
36. Mannino M.M. et al. Current teatment options for paroxysmal supraventricular tachycardia. – Am. Heart J., 1994; 127: 475-480.
37. Santinelli V. et al. Paroxysmal supraventricular tachycardia: Experience with propafenone. – Angiology, 1989; 40: 563-568.
38. Chimenti M. et al. Tolerance and efficacy of flecainide versus propafenone for the long-term management of paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. – Circulation, 1993; 88: I-446 (abstract).
39. Prichett E.L. et al. Comparison of mortality in patients treated with propafenone to those treated with a variaty of antiarrhythmic drugs for supraventricular arrhythmias. – Am. J.Cardiol., 1993; 72: 108-110.
Рецензия
Для цитирования:
Преображенский Д.В., Маренич А.В., Андрейченко Т.А., Киктев В.Г., Сидоренко Б.А. ПРОПАФЕНОН: КЛИНИЧЕСКАЯ ФАРМАКОЛОГИЯ И ЭФФЕКТИВНОСТЬ ПРИ СУПРАВЕНТРИКУЛЯРНЫХ ТАХИАРИТМИЯХ (Часть вторая). Российский кардиологический журнал. 2001;(5):78-84.
For citation:
Preobrazhensky D.V., Marenich A.V., Andreychenko T.A., Kiktev V.G., Sidorenko B.A. PROPAPHENON: CLINICAL PHARMACOLOGY AND EFFICACY IN SUPRAVENTRICULAR ARRHYTHMIAS (PART 2). Russian Journal of Cardiology. 2001;(5):78-84. (In Russ.)
Просмотров:
304
Послать статью по эл. почте 